The adoption of vendor managed inventory for hospital pharmaceutical supply by Krichanchai, Sineenart & MacCarthy, Bart L.
1 
 
 
 
THE ADOPTION OF VENDOR MANAGED 
INVENTORY FOR HOSPITAL PHARMACEUTICAL 
SUPPLY 
 
 
 
Sineenart Krichanchai1 and Bart L. MacCarthy1* 
  
1 Nottingham University Business School, The University of Nottingham, Jubilee Campus, 
Nottingham, NG8 1BB, UK. 
 
 
 
 
 
 
* Corresponding author (Bart.MacCarthy@nottingham.ac.uk). 
To Cite: 
Krichanchai, S., & MacCarthy, B. L. (2016). ‘The Adoption of Vendor Managed Inventory for 
Hospital Pharmaceutical Supply’, International Journal of Logistics Management, in print. DOI 
(10.1108/IJLM-01-2015-0010); 
  
2 
 
 
Abstract 
The study investigates Vendor Managed Inventory (VMI) for the supply of medicines between 
distributors and hospitals to identify factors that may affect VMI adoption. Multiple case studies 
are conducted involving five organizations (three hospitals, one distributor, and one 
manufacturer/ supplier). Four dyadic relationships are identified. Triangulation techniques are 
used in data collection, including interviews, site visits and document analysis to enhance 
reliability and validity. Case studies have been analyzed individually and comparatively. Two 
types of VMI initiatives – public and private sector - are identified in the supplier/hospital 
context. The public sector supplier focuses on improving service level while the private sector 
supplier seeks to strengthen relationships with key customers. Hospital characteristics, including 
the type of hospital, top management perspectives, and the hospital’s willingness to share 
information, are critical in decisions on VMI initiation or termination. Relatively stable demand 
products are preferred for a VMI approach. Hospitals may perceive risks in VMI adoption for 
medicines as it involves relinquishing  control of critical supplies and may result in ‘lock-in’ with 
a particular supplier. The paper provides supply side and demand side perspectives on VMI 
adoption in an important sector. It highlights the need for greater understanding of the perceived 
and actual risks in VMI from the perspective of both the hospital and the supplier and for much 
clearer advice on which pharmaceutical products are appropriate for VMI control in a hospital 
context.  VMI is advocated as being beneficial in many supply contexts. However, it may be 
challenging to implement. This study identifies a range of factors that affect the adoption of 
VMI in hospital pharmaceutical supply chains. The cases have been conducted in one country, 
which may affect the generalization of the findings.  Wider empirical evidence from other 
countries in both developed and less developed regions will be beneficial.   
 
Keywords: Vendor Managed Inventory, Hospitals, Pharmaceutical products, Pharmaceutical 
suppliers, Pharmaceutical distributors 
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1. INTRODUCTION 
During the last two decades a number of supply chain initiatives have been introduced to 
improve inventory and demand management (Simchi-Levi et al., 2007). One such initiative is 
Vendor Managed Inventory (VMI). In contrast to traditional inventory management, the 
fundamental concept in VMI is to shift responsibility for replenishment decision making from 
the customer to the supplier or vendor (who may or may not be a producer). To support the 
supplier in doing so, the customer is required to share or make visible demand information to 
the supplier (Govindan, 2013). 
 
The adoption of VMI has been considered in various sectors including the retail sector, 
manufacturing (Zachariassen, et al. 2014), and the food and beverage industries (Stanger, 2013). 
The approach has also been considered for the healthcare industry (Bhakoo et al., 2012). 
Healthcare organizations are continually seeking opportunities to reduce costs and improve 
operational efficiencies while improving the quality of care (Chen et al., 2013). Changes have 
occurred in healthcare environments owing to increasing healthcare costs, intense competition 
and complex requirements and regulations. These have accelerated the focus on making 
healthcare supply chains more demand-driven, increasing collaboration between the various 
parties involved in supply and implementing more and better standards (Rossetti et al., 2012). 
Given the claimed potential benefits of VMI, including performance improvement, cost 
reduction and improved customer satisfaction, the approach has come to the attention of 
pharmaceutical companies, medical and pharmaceutical distributors and healthcare providers 
including hospitals (Haavik, 2000; Danese, 2006; Mustaffa and Potter, 2009 ; Turhan and 
Vayvay, 2009). However, VMI has not become a standard mode of operation in supply chains 
(Niranjan et al., 2012).  
 
Implementing VMI does not in itself ensure that organizations will gain the advantages and 
benefits claimed. There are challenges in introducing, managing and sustaining VMI initiatives 
that may reduce the benefits or lead to failure in implementation. The literature has noted lack of 
trust, inaccurate information sharing, information transmission delays, and inefficient co-
ordination as potential challenges in VMI adoption (Waller et al., 1999; Sari, 2007; Niranjan et al., 
2012).  The challenges and benefits may differ significantly in different contexts (Elvander et al., 
2007). It is evident that “VMI may not be a universally applicable solution” (Niranjan et al., 
2012, pp.939).  The main purpose of this research is to investigate whether VMI is beneficial for 
pharmaceutical supply in a hospital context, so that healthcare organizations can make better 
4 
 
decisions about VMI adoption. In this context pharmaceutical refers specifically to the supply of 
medicinal products to hospitals. We consider the direct supply of medicines between distributors 
or other suppliers and hospitals, which is an important and common scenario in the healthcare 
sector (Rossetti et al., 2012).  
 
The rest of the paper is structured as follows. In the next section, literatures related to the 
emergence of the VMI approach and VMI in healthcare supply chains are considered.  Issues 
and challenges on VMI adoption and implementation are identified related to supplier 
characteristics, hospital characteristics, product characteristics and supply chain integration.  
Next, the methodology for this qualitative exploratory study is described. Two contrasting cases 
involving four dyadic relationships in Thailand are analysed with regard to the issues and 
challenges identified. The following section analyses and discusses the findings and their 
implications. The paper then presents the study conclusions. The study shows that the VMI 
approach can be adopted within a hospital context for pharmaceutical products but that it raises 
issues and challenges for both the supplier and the hospital. 
2.LITERATURE REVIEW  
2.1 Emergence of the VMI approach 
A number of collaborative inventory management approaches have emerged, particularly in 
relation to the retail industry, including information sharing, category management (CM), 
continuous replenishment process (CRP), collaborative planning, forecasting and replenishment 
(CPFR), and VMI.  Holweg et al. (2005) classified approaches on a continuum from a traditional 
approach without collaboration to approaches distinguished by differences in collaboration on 
inventory control and collaboration on planning.  Information sharing is a step on the 
collaboration continuum. Suppliers and customers still work relatively independently but agree to 
share some demand information to enhance alignment. Angulo et al. (2004) discussed the 
concept of a continuous replenishment process (CRP), which is based on information sharing 
among supply chain members in order to match supply and demand as closely as possible. Under 
a Category management (CM) approach, marketing information is shared with a supplier to 
enhance the supplying firm’s understanding of changing demand patterns and consumer 
preferences (Dewsnap and Hart, 2004; Chun and Cadeaux, 2009). Holweg et al. (2005) note that 
Collaborative Planning, Forecasting and Replenishment (CPFR) is a further step in information 
sharing in which both vendor and customer firms conduct planning and forecasting processes 
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jointly. This has the potential to enhance forecast accuracy and demand visibility and lead to 
improved business performance, cost savings and higher revenues (Ramanathan, 2014).  
 
Vendor-Managed Inventory (VMI) is a supply chain initiative that also requires information 
sharing between trading partners. However, unlike other collaborative approaches, VMI is 
unique in requiring a transfer of decision making from the customer to the supplier or vendor, 
which moves it beyond information sharing.  Walmart and Procter and Gamble were early VMI 
pioneers in the retail sector (Niranjan et al., 2012).  The potential benefits have been clear since 
the adoption of this approach in the early cases (Dong et al., 2014). Since then, both empirical 
and modeling research studies have been conducted in order to analyze VMI, its adoption and 
implementation. A number of empirical research studies have investigated the value of VMI 
adoption and addressed the factors that impact on VMI success (Kaipia et al., 2002; Classen et 
al., 2008; Kauremaa et al., 2009). Classen et al. (2008) used a survey study to examine the buyer's 
perspective on how VMI success related to firms' performance outcomes, revealing that buyers 
perceived that VMI impacts significantly on customer service, supply chain control and cost 
reduction. Kaipia et al. (2002) conducted a case study in the grocery industry to determine the 
potential benefits to suppliers, suggesting that it provides time benefits to the suppliers to 
operate stock management effectively.  
 
Kauremaa et al.,(2009) propose five inhibitors in VMI implementation, including brand offering, 
buyer professionalism, and supplier's large delivery batch size relative to customer's demand, 
supplier's small share of total business and supplier's long product life cycle length. These 
inhibitors affect the buyer's dependence on the supplier and the buyer’s perceived value of VMI.  
The study by Elvander et al., (2007) proposes a framework with four dimensions for 
characterizing the design of VMI systems: inventory-related dimensions, information-related 
dimensions, decision-making related dimensions and system integration level dimensions. 
Niranjan et al., (2012) develop an assessment for VMI readiness, which focuses on three 
features: product-related, company-related, and supplier-related features. 
 
Analytical models and simulation models have also been employed to study VMI. Modeling 
studies relate to supplier aspects, customer aspects, supply chain integration aspects and product 
aspects (Waller et al., 1999; Angulo et al, 2004; Yao and Dresner, 2008; Mateen and Chatterjee, 
2015).  Waller et al., (1999) explore how VMI performs under particular constraints including 
different levels of demand variability, limited manufacturing capacity and partial channel 
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adoption. Using a simulation model, Angulo et al., (2004) evaluate the information sharing 
effects of variation in demand and lead time on VMI. The results show that information delay 
impacts on performance measures significantly, while information accuracy does not. 
Researchers have studied the value of the VMI approach compared with other supply chain 
integration approaches (Sari, 2008; Mateen and Chatterjee, 2015). Sari (2008) developed a 
simulation study to compare the performance improvement gained from VMI and Collaborative 
Planning, Forecasting and Replenishment (CPFR). The study indicated three factors that affect 
performance improvements obtained from both approaches; capacity tightness of the plant, 
replenishment lead times and uncertainty in market demand. Kamalapur et al. (2013) examine a 
dyadic relationship between a manufacturer and a retailer. The study compares cost performance 
under three approaches - traditional, VMI and CPFR   using a simulation model - and examines 
the factors affecting the benefits gained from a VMI approach under a range of conditions. The 
study suggests that VMI enables cost saving at both manufacturer and retailer but under most 
supply chain settings, greater cost benefits are achieved in CPFR compared to VMI. Wei et al. 
(2014) compares benefits of VMI and CPFR in a four stage supply chain using simulation model. 
The results indicate that VMI gives lower benefit than CPFR when operating under (R,Q) policy. 
Mateen and Chatterjee (2015) use a mathematical model to compare retail managed inventory 
with four VMI models capturing different operating systems. The results suggest that the 
benefits of VMI depend on the operation system. Choosing the right policy is important, which 
should be based on real cost parameters. 
 
2.2 VMI in the hospital industry 
Hospital supply chains differ in a number of respects from those in manufacturing and retail 
industries (de Vries, 2011; Chen et al., 2013).  While a manufacturer may seek to optimize the 
added economic value in the supply chain, the hospital’s main purpose is to provide added 
clinical value (McKone-Sweet et al., 2005; Gehmlich, 2008).  Hence, healthcare providers seek to 
ensure that medical stocks are available when needed. The simplest way to ensure stock 
availability is to maintain high stock levels, but of course this may lead to a high percentage of 
the available budget being tied up in inventory (de Vries, 2011). Additionally, medicines may 
have time limits on how long they can be stored before use. 
Product demand in a hospital setting may have a high variability as illness is unpredictable. A   
patient’s condition, including physical and mental state, individual drug tolerance, how the 
patient responds to medicines as well as compliance issues all have an impact on product 
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demand (Gehmlich, 2008; Vila-Parrish et al., 2008). de Vries (2011) points out that inventory 
systems in healthcare are influenced by multiple stakeholders.  Patients in hospitals do not select 
the product themselves. It requires professional healthcare staff to make a decision to select an 
appropriate product based on patient condition and clinical preference (Burns et al., 2002; Chen 
et al., 2013).  
Some literature has discussed VMI in healthcare settings. Haavick (2002) considers VMI 
implementation in hospitals in the US, suggesting that optimum use of VMI requires hospitals to 
improve data collection and work with suppliers in establishing electronic communication 
systems. Mustaffa and Potter (2009) focus on healthcare supply chains in Malaysia. They argue 
that, owing to transportation constraints in developing countries, VMI may be an appropriate 
solution for the current situation of healthcare industry in comparison with two other 
collaborative approaches - JIT and a stockless approach.  Turhan and Vayvay (2009) use a 
service-oriented architecture to model VMI implementation in a hospital. The system shows how 
information sharing and business reengineering affect cost reductions realized from VMI.   
Bhakoo et al. (2012) explore collaborative inventory management approaches in Australian 
hospital supply chain. They identify product characteristics as one of five contingent factors 
affecting the development of collaborative relationships. Matopoulos and Michailidou (2013) use 
a single case study to investigate VMI implementation for five medical devices in a Greek 
hospital. The results presented suggest that the hospital may gain benefit from reductions in 
overstocking and the number of expired supplies. Watson et al., (2012) report on a VMI project 
for public health initiatives for USAID and propose five VMI models to be implemented in a 
public healthcare supply chain. The report suggests that VMI can bring benefits to the public 
sector.  However, there are significant challenges in the public sector related to health programs, 
infrastructures, products, potential VMI partners and stakeholders. Stanger (2013) developed a 
general framework to assess VMI implementation. It has a particular focus on two customer 
perspectives - the ability to implement VMI from technical and organisational perspectives and 
the willingness to implement VMI. 
It may be challenging when implementing approaches developed in other business or industrial 
settings in a healthcare service setting in a hospital (McKone-Sweet et al., 2005; Gehmlich, 2008). 
Hans et al. (2012) points out that the supply chain approach may need to be adapted in order to 
be suitable for hospital characteristics. It is not clear from the literature if and when VMI will be 
successful in hospital pharmaceutical supply chains.  Here we consider the issue further in 
relation to supplier, hospital, product and supply chain integration characteristics.   
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2.2.1 Supplier characteristics 
There are several types of potential pharmaceutical suppliers including pharmaceutical 
manufacturers, international distributors and local distributors (Management Sciences for Health, 
2011). Different types of suppliers have different characteristics in terms of their ownership, 
sources of funding, location, product ownership and market positioning, which may result in 
different objectives, culture and business strategy (Kimberly and Evenisko, 1981; Management 
Sciences for Health, 2011).  Holweg et al. (2005) suggest small-sized local companies should 
implement synchronized collaboration with its major customer to enhance customer 
responsiveness while it may not be economically viable for a multinational company, which has a 
large number of different customers and distribution channels, to move away from a traditional 
approach. Therefore, the type of supplier may affect the feasibility of VMI implementation.   
The customer may seek to persuade the supplier to adopt a VMI approach in order to improve 
its operational efficiency and its commercial position (Niranjan et al., 2012; Kauremaa, et al., 
2009). It may be persuasive for a supplier to engage in a VMI approach if the organization that is 
interested is a key customer. It may allow the supplier to gain a higher percentage of sales and 
become a preferred supplier (Niranjan et al., 2012). However, the supplier’s capability to handle 
the flow of information and the flow of physical stock to meet customer demand needs to be 
considered (Angulo et al., 2004; Kuk, 2004; Power, 2005). This may also affect the customer’s 
trust in the supplier. Inability to perform properly leads to customer dissatisfaction and may fail 
to persuade the customer to engage in a collaborative approach or result in them terminating 
such an approach (Vigtil, 2008).  If an organization perceives its performance is sufficient to 
compete against the other rival companies, they may not be interested in implementing different 
supply chain management initiatives (Danese et al., 2006).  
2.2.2  Hospital characteristics 
Several aspects may be used to characterize and classify hospitals including size, ownership and 
control (Government and Private), the services provided (General and Specialty), the level of 
service capabilities (Primary, Secondary and Tertiary), teaching status (Training and Non-
training), location (rural, urban) (Elixhauser et al., 2003; Jacobs and Chase, 2014). The size of the 
organization is one aspect that may affect the adoption of new supply chain integration initiatives 
(Power, 2005; Jacobs and Chase, 2014). The size of hospital can relate to the complexity of 
operations and the use of technology (Jacobs and Chase, 2014; Nawanan, 2011). Large hospitals 
have more capital resources and can afford to invest in initiatives and technology to a greater 
degree than smaller hospitals. The operational and administrational aspects of larger hospitals 
require more sophisticated IT systems to manage the complexity of their operations.   
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Moreover, the type of organization may also lead to different objectives and business strategies 
(Lee and Xia, 2006; Weng et al., 2011). Classifying the type of hospital by source of funding may 
reflect how the hospital perceives market pressure (Aptel and Pourjalali, 2001). In general, 
hospitals can be categorized into two groups - publicly owned and privately owned hospitals. 
Privately owned hospitals (or for-profit hospitals) are positioned in a competitive market as 
funding is generated from patients receiving healthcare services from the hospital.  Such 
hospitals need to employ flexible strategies and adopt information technology to improve 
performance and to outperform competitors. The public hospital may have less market pressure 
and may have less motivation to employ new approaches to improve efficiency and quality 
(Nawanan, 2011; Weng, 2011), although this is changing with healthcare budgets being squeezed 
in many countries. 
The adoption of VMI cannot occur without the customer’s willingness to share information. 
Information integration requires strong communication between trading partners (Power, 2005; 
Vigtil, 2008). The supplier may need to develop trust and a relationship with the customer so 
that it can persuade the customer to collaborate and share information related to demand and 
inventory levels. However, even though healthcare organizations may perceive the benefits that 
could be gained from information integration, there may be a resistance to share confidential 
information due to lack of reciprocal trust (Turhan and Vayvay, 2009). There may be a conflict 
of interest between the hospital and its supplier. The hospital aims to maximize healthcare 
service and control stock volume in the hospital’s inventory while the pharmaceutical supplier or 
manufacturer seeks increasing market share and may ‘push’ products to the hospital (McKone-
Sweet et al., 2005; Gehmlich, 2008). This may lead to distrust between trading partners and thus 
it may be challenging to adopt collaborative approaches such as VMI in the healthcare industry.  
Furthermore, top management commitment has been noted as one of the key success factors for 
supply chain projects. Clear commitment from top management presents a signal to employees 
that the project needs to get the necessary attention and priority (Brinkhoff et al., 2015). Vigtil 
(2008) also points out that this is vital for a change process like VMI. It requires the hospital’s 
top management commitment and appropriate decisions to reengineer the existing process and 
give encouragement to the workforce to get involved in the project. 
2.2.3 Product characteristics 
Consideration of product characteristics is crucial for the selection of an inventory control policy 
and replenishment process (Silver et al., 1998; Management Sciences for Health, 2011). 
Inventory management generally categorizes products based on the value of products by using 
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ABC analysis, the amount of product (high-volume or low-volume), and the movement of 
product (fast-moving product or slow-moving product) (Silver et al., 1998). However, hospitals 
have to be concerned with other tools including VEN analysis and therapeutic categories of 
medicines (Management Sciences for Health, 2011).    
Regarding VMI studies, previous literature mostly believes that high-volume products are 
appropriate for starting this collaborative approach (Waller et al, 1999; De Toni and Zamolo, 
2005). On the other hand, Vigtil (2008) found that VMI can provide less benefit for high-volume 
products, contradicting previous research.  Disney and Towill (2003) suggest that VMI can 
provide benefits for both low-volume products, which suffer from the Burbidge effect and high-
volume products which suffer from the bullwhip effect. In terms of product value, Vigtil (2008) 
notes that VMI is suitable for products that suffer from the bullwhip effect, which are typically B 
and C class based on the value of products but it is quite interesting that she still recommends 
suppliers to employ a VMI approach with A class products.  
Smaros et al. (2003) note that demand visibility arising from VMI implementation can provide 
benefits for products with low replenishment frequencies especially type C products. Kaipia et al. 
(2002) opposes this view, arguing that VMI can provide more benefit to unstable demand 
products because these products tend to have longer manufacturing throughput time. Smaros et 
al. (2003) suggests that stationary demand products can gain benefit from improvements in 
demand visibility resulting from VMI adoption. However, Vigtil (2008) states that demand 
variability is not a determinant for the success of VMI. The crucial factor is demand 
predictability. Especially for high demand uncertainty, high quality of demand information and 
efficient information sharing are required. Functional products are proposed as ideal candidates 
for this collaborative approach. It is found that products with high demand and supply elasticity 
are likely to persuade the trading partners to engage in a collaborative approach (Danese, 2007;  
Bhakoo et al., 2012). Moreover, some studies suggest a VMI approach could be used in hospital 
pharmaceutical supply chains (Kim, 2005; Watson et al., 2012; Guimaraes et al., 2013) while 
other studies argue that it is not suitable for medicine supplies in the hospital (Bhakoo et al., 
2012; Matopoulos and Michailidou, 2013). It is still unclear whether it is appropriate to apply this 
approach to manage hospital stocks for medicines. 
2.2.4 Supply chain integration characteristics 
Several studies have discussed how healthcare organizations can collaborate with trading partners 
with approaches varying from a traditional arm’s length approach, to Just-In-Time, VMI, CPFR 
and Stockless supply (Rivard-Royer et al., 2002; Danese et al., 2006; Mustaffa and Potter, 2009). 
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Danese et al., (2006) point out that the current state of supply chain integration (SCI) and the 
external competitive context are the factors that determine subsequent initiatives. Power (2005) 
highlights that supply chain integration consists of three mains aspects: the management of 
information flows; the management of material flows; and the management of relationships 
between partners.  
Regarding the flow of information, Angulo et al., (2004) in their modelling study, suggest that 
customers should share information related to inventory levels, inventory position, sales data and 
forecasts with suppliers. Vigtil (2008) states that it is most important to share inventory levels 
with the supplier. However, additional information including production schedules, point of 
sales data or stock withdrawals may be considered but the information that needs to be shared 
depends on the type of suppliers (manufacturers or wholesalers) and type of production (make-
to-stock or make-to-order). Niranjan et al. (2012) highlights that standardization of product 
identification codes should be put in place in order to enhance data transmission.   
In terms of information systems, the literature discusses the significance of integrated 
Information communication technology (ICT) for the implementation of VMI. Generally, there 
are two types of data transfer - manual transference using phone or fax, and electronic transfer 
using EDI, XML, or internet (Holmstrom, 1998; Waller et al., 1999; Vigtil, 2008). Vigtil (2008) 
mentions that the use of electronic data transfer may not be a guarantee for success but it can 
offer a positive contribution to VMI implementers. Waller et al. (1999) argue that suppliers can 
monitor customer’s inventory by physical or electronic messaging. They also state that EDI is 
only an enabler but not a prerequisite factor. This is also supported by the work of Holmstrom 
(1998), which shows that data transmission for VMI implementation can be done manually by 
fax, email and by spreadsheet. The level of information integration has been discussed by Vigtil 
(2008). She describes the level of data transmission based on the combination of transfer means 
and frequency. 
With respect to VMI implementation, it is suggested that the issues related to physical flows 
should be clearly discussed and be agreed in the contract in terms of inventory location, 
inventory ownership, replenishment decisions and performance measurement (Elvander et al., 
2007, Vigtil, 2008). For the healthcare industry, the inventory is likely to be located at a hospital 
in order to ensure product availability when it is needed (Aptel and Pourjalali, 2001; Turhan and 
Vayvay, 2009). Furthermore, good relationships and trust between partners can reflect positive 
attitudes about each other’s motive, which is considered a factor in VMI implementation 
(Danese et al., 2006; Vigtil, 2008; Kauremaa et al., 2009).  
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The analysis of the literature identifies several research gaps. Firstly, VMI implementation varies 
in different industries due to different characteristics within that industry. Even in the same 
industry, VMI also varies in the different contexts of the supply chain. Although there is some 
relevant previous literature in the healthcare sector, research specifically related to VMI 
implementation for the supply of medicines to hospitals is still very limited and the conditions 
under which VMI is likely to be successful are still unclear and not understood. Secondly, it is 
still unclear whether it is appropriate to apply this approach to manage stocks for medicines. 
Some studies suggest that hospitals may adopt the approach for managing pharmaceutical 
supplies because of the higher service level and the integrated information systems. However, 
some studies argue that pharmaceutical supplies are not feasible for a VMI approach. Some 
recommend VMI implementation with non-pharmaceutical healthcare supplies that have high 
value and short life items instead of routine medicines. Previous VMI studies in a hospital 
context have not discussed which particular products should be managed with a VMI approach. 
Thirdly, the literature notes that intermediaries such as distributors and wholesalers play an 
important role in hospital pharmaceutical supply chain. Regarding VMI in a hospital context, this 
approach is most likely to be implemented with an intermediary such as a distributor or 
wholesaler. To address these gaps this study investigates VMI adoption for pharmaceutical 
supply chains in a hospital context to add to the very limited empirical evidence on VMI 
adoption in this sector.  The analysis is conducted with regard to hospital characteristics, supplier 
characteristics, product characteristics and supply chain integration characteristics and how they 
may affect the likelihood and feasibility of VMI adoption.  
3. METHODOLOGY 
The objective of this exploratory research is to investigate whether VMI adoption is relevant, 
feasible and beneficial to the healthcare industry particularly for the supply of medicines to 
hospitals. A multiple-case study approach is employed to explore the rich picture of the 
pharmaceutical supply in the hospital context.  A case study allows the researcher to ‘investigate 
a contemporary phenomenon in depth and within its real-life context when the boundaries 
between phenomenon and context may not be clearly evident’ (Yin, 2013, pp.16). Multiple case 
studies can augment external research validity and create more testable theory than single cases 
(Barratt et al., 2011; Voss et al., 2002).  Here the cases are first briefly described and then their 
selection is justified.  
The study presents two contrasting VMI projects within a hospital pharmaceutical context - a 
successful VMI project consisting of one public manufacturer (who also acts as a distributor) and 
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three hospitals (three dyads), and an unsuccessful VMI project consisting of a private distributor 
and one hospital (one dyad). The case studies presented here have been conducted in Thailand.  
The two projects involved three hospitals - HA (university hospital), HB (provincial hospital) and 
HC (private hospital) – that differ in terms of ownership, size of hospital and location. HA is a 
large sized hospital (1,200 beds) while HB and HC are medium-sized (300 beds and 400 beds 
respectively). HA and HB are state-owned hospitals while HC is part of a private hospital group.  
Both HA and HC are located in the capital city while HB is located in a rural area.  All three 
hospitals (HA, HB and Hc) are currently engaged in a sucessful public VMI project with the public 
manufacturer while one of the hospitals (HA) also engaged in a VMI project with a private 
distributor.  However, this project was not sucessful and was terminated for pharmaceutical 
supplies. 
 
The public VMI project is a major project for the supply of antiretroviral products to enhance 
product affordability and accessibility for HIV patients. Under this program, the public 
manufacturer (M) receives funds and is authorized to adopt a VMI approach for antiretroviral 
products. The hospitals that enroll in this project agree to be supplied by the public 
manufacturer and receive free antiretroviral products. The VMI project with the private 
distributor (D) had been considered and trialed but the hospital partner (HA) subsequently 
discontinued the implementation with the private sector distributor.  For the remainder of this 
paper we label the successful VMI initiative as the public project and the unsuccessful one as the 
private VMI project. 
 
Four tests developed by Yin (2013) for research design were considered to judge the quality of 
the case study research and are summarized in Table 1. These include construct validity, internal 
validity, external validity and reliability. The table explains the approaches used to ensure validity 
and presents the phase of the research in which each approach was adopted with an example of 
how each approach was employed. Regarding construct validity, multiple sources of evidence 
were employed for data collection.  Semi-structured interviews were used as the primary data 
collection approach, while observation and documentation were also gathered for triangulation 
purposes.  
 
Internal and external validity is also of concern when we select a case study. Case selection may 
be based on theoretical sampling in order to either predict similar results or show contrasting 
characteristics (Stuart et al., 2002; Voss et al., 2002). Two contrasting cases were considered in 
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this study that would allow the researcher to examine and compare VMI in public and private 
sector settings and also one that had been a success and one that had failed to go into operation. 
Table 2 provides summary details of each entity in each case as well.  The selection was also 
motivated by the accessibility of the cases to the researcher. 
 
Table 1: The assessment of quality of research design 
Test Case study tactic Phase of research in 
which tactic occurs 
Approach 
Construct 
validity 
Use multiple 
sources of evidence 
Data collection, 
Data analysis 
 Triangulation is used in data 
collection and analysis, e.g. 
data collection is conducted 
via interviews, observation 
and documentation. 
Internal validity Do pattern 
matching 
Data analysis  Similarities and dissimilarities 
across the case studies are 
considered in data analysis, 
e.g. the public and private 
VMI cases are compared 
across each of the four 
themes to identify similarities 
and differences.  
External validity Using replication Research design, Data 
analysis 
 Theoretical sampling was 
used for case selection. Two 
different and contrasting VMI 
cases were selected, e.g. one 
was in the public sector while 
the other was in private 
sector. The cases were 
analyzed based on the same 
structural themes -hospital, 
supplier, product and supply 
chain integration 
characteristics. 
Reliability Using case study 
protocol 
Data collection  Interview guides were 
developed and used for semi-
structured interview in all 
cases. These are presented in 
the appendix. 
 
 
The selection allows the researcher to investigate factors that affect the continuation of a VMI 
program in a hospital context. Selecting these cases also enabled exploration of the 
characteristics of VMI with different types of hospitals. As the case studies were conducted from 
both the hospital and supplier/distributor perspectives, they also provide views from both sides 
of the dyad in a VMI program. Regarding reliability, detailed interview guides and questionnaires 
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were developed before conducting the case studies. The interview guides aligned with the 
research objectives and covered the four main themes discussed in the literature review:  
(1) Supplier/distributor characteristics  
(2) Hospital characteristics  
(3) Products characteristics  
(4) Supply chain integration characteristics. 
  
The questionnaires used in the interview were created based on previous VMI studies and the 
supply chain management literature in the healthcare arena (Aptel and Pourjalali, 2001; Vigtil, 
2008). Two sets of interview guides were developed – one for distributors and one for hospitals. 
The VMI questionnaires were designed to understand how VMI was initiated, designed and 
conducted. The interviewees were questioned on whether the type of VMI partner (either 
hospital or supplier) influenced the decision to adopt VMI. The flow of material and information 
was discussed and the types of product involved and the demand information shared between 
parties were considered. The questionnaires used are extensive. The key questions that guided 
the interview are summarized in the Appendix1 . The interviewees were 3 pharmacists with 
inventory management responsibilities in the hospitals and 2 managers with responsibilities for 
managing and setting inventory policies at the distributors. Each interviewee had strong 
involvement in the VMI projects at the case study sites. The interviews were conducted at the 
case studies sites with follow up phone calls for clarifications where necessary. 
Table 2: Summary of each entity in the two case studies 
 HA HB Hc D M 
Type of 
hospital or 
supplier 
Public hospital 
(1,200 beds)  
Public hospital 
(300 beds) 
Private hospital 
(400 beds) 
Private 
distributor (D) 
 
Public 
manufacturer 
(M) 
VMI project Public and 
private VMI 
Public VMI Public VMI Private VMI Public VMI 
Initiator/ 
Implementer 
Initiator and 
Implementer 
Implementer Implementer Implementer Initiator 
VMI products Antiretroviral 
products 
Smooth 
demand 
products 
Antiretroviral 
products 
Smooth 
demand 
Free products 
Antiretroviral 
products 
Smooth 
demand 
Free products 
Smooth 
demand 
products 
Antiretroviral 
products 
Smooth 
demand 
Free products 
Current VMI 
status  
Continued 
using public 
VMI and 
Discontinued 
private VMI 
Continued 
using public 
VMI 
Continued 
using public 
VMI 
Discontinued 
private VMI 
Continued 
using public 
VMI 
                                                          
1
 The full questionnaires are available from the authors 
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Theoretical propositions or constructs provide a strategy to both collect data and shape the way   
case studies are analyzed (Yin, 2013). Hence in this study, the cases are analyzed considering the 
four main themes identified in the literature review above - supplier characteristics, hospital 
characteristics, product characteristics, supply chain characteristics. Pattern matching and cross-
case synthesis are employed as case analysis techniques for this study (Yin, 2013). Using pattern 
matching requires the researcher to match similar outcomes and identify differences, which helps 
strengthen internal validity. Cross-case synthesis was performed to identify general themes, 
similarities and differences across the case studies. Section 4 below presents the outcome of the 
analysis under the main four headings. 
4. ANALYSIS  
The analysis of the public and private VMI cases is based on a detailed analysis of the evidence 
gained from each of the three hospitals and two distributors. The results of the analysis are 
discussed in detail below with regard to supplier characteristics, hospital characteristics, product 
characteristics, and supply chain characteristics. Table 3 summarizes the evidence for each 
element of the analysis and shows the relevant supplier and hospital questions that helped to 
support the analysis and discussion of the findings. Table 3 is structured in the same way as the 
discussion below. Table 4 summarizes the finding.  
4.1 Supplier characteristics 
Type of supplier 
Two types of supplier are evident in the cases - a private distributor (D) and a public 
manufacturer (M), who also acts as a distributor. The case studies show that type of supplier 
influences VMI adoption. The private VMI project was initiated between the private distributor 
and hospital Ha. The decision to initiate this collaborative approach was made by the hospital 
HA. The hospital selected this distributor for VMI adoption because the distributor is a large 
organization that provides many products and high volumes of pharmaceutical supplies directly 
to the hospital and was viewed as having the potential to engage in VMI.  For the public VMI 
project, which operates under the national health scheme, the public manufacturer is responsible 
for distributing antiretroviral products. Hospitals that enroll in the national health scheme 
receive free products based on the number of registered patients. Also private hospitals are 
allowed to engage in this national health scheme project. This expands the distribution channels 
of the products to patients while the private hospital receives free products and reimbursement 
for other relevant services. This is persuasive for both public and private hospitals to engage in 
VMI projects with the public manufacturer.   
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In conclusion, it is evident in each case that the type of supplier affects the likelihood and 
feasibility of the VMI approach being initiated in a hospital setting. For the public manufacturer, 
it is possible to implement VMI as the program operates and is funded under the national health 
scheme.  This is persuasive for the various types of hospital to engage with this program. 
Regarding the private distributor, it prefers to implement a VMI approach with the larger sized 
hospital. However, it is difficult for a private supplier or distributor to be the initiator of VMI 
with this type of hospital as the hospital has greater bargaining power. The hospital itself typically 
decides whether such a project should be initiated, implemented and adopted.  
 
Supplier resources, capabilities and performance 
Supplier performance is another factor affecting the likelihood and feasibility of VMI adoption. 
It needs to be evident that the supplier is capable of handling the flow of information and 
physical stock in order to facilitate the smooth implementation of VMI (Power, 2005; Vigtil, 
2008).  The private distributor (D) owns the largest warehouse in Thailand and has 5 cross-
docking distribution centers across the country to facilitate and enhance timely distribution. IT 
applications and warehouse management systems are also employed to support information 
visibility and improve stock management. This enables the company to deliver products at the 
right place, at the right time and in the right quantity. Therefore, hospitals tend to be satisfied 
with the company’s performance. For the private VMI project with hospital (HA), the hospital 
was willing to collaborate with the distributor (D) as it is a key supplier and has the capacity to 
undertake and manage a VMI project.  
 
For the manufacturer (M), as the company is a publicly owned organization, it also has the 
capability to invest in the logistic systems to ensure product availability and supply to the 
hospital. Hospitals that enroll in the VMI project with the manufacturer do not bear the costs 
for products or services as the manufacturer receives funds from the government to facilitate 
national distribution channels.  Thus it is evident that both supplying companies have the 
capabilities to ensure product availability and are ready to engage with VMI projects, which 
ensures the feasibility of using a VMI approach.  
 
Willingness to undertake a VMI project 
Both the private distributor and the public manufacturer were willing to be involved in VMI 
projects, even though the goals and purposes of the VMI initiative are different due to the 
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characteristics of the organizations involved and the context. For the private VMI project, the 
hospital (HA) is a key customer from which the distributor gains a high percentage of sales. The 
distributor considers engaging in the collaborative approach to help it to provide better service, 
improve resource utilization and importantly, secure customer retention in a highly competitive 
market situation. Hence the distributor decided to respond positively to the request from the 
hospital and proposed that it would be responsible for developing information systems in order 
facilitate information flow.  
VMI initiation was considered based on its strategic, operational and financial goals. For the 
public VMI project, the public manufacturer is responsible for ensuring product availability and 
accessibility to as many HIV patients in the country as possible. Implementing a VMI approach 
can ensure customer service improvement and product accessibility. As the manufacturer 
considers the benefits to be gained from this approach, it is willing to invest time and resources 
by providing the training and IT infrastructure to attract both public and private hospitals to 
enroll in the public VMI project.  
 
4.2 Hospital characteristics 
Type of hospital 
For the public VMI project, the characteristics of the three hospitals are different with respect to 
ownership, size, and location. However, it was not evident in these three cases that the type of 
hospital affected their decisions on VMI adoption for this public VMI project. As the objective 
of the government project is to enhance medicine accessibility for HIV patients, it seeks to 
ensure successful VMI adoption and implementation in all types of hospital.  
 
In contrast only the public hospital HA was involved in a VMI project with a private supplier. 
The difference between this hospital and the other two hospitals is that it is a large hospital with 
more than 1000 beds.  As such, the hospital is a key customer of the private distributor. It has 
bargaining power to negotiate with the distributor to engage in this collaborative approach. 
Moreover, HA also has the capability to invest in high quality medical equipment, technology and 
information systems to provide high quality medical services. However, when the other hospitals 
were asked about wider adoption of VMI, neither had considered VMI adoption with private 
distributors or suppliers.  For the provincial hospital HB, they noted that, owing to the success of 
the VMI project with the public sector, it would be interesting to engage in a VMI project with a 
private supplier. However, given the small size of this hospital they noted that it may not be 
attractive for private suppliers to invest and engage in VMI projects with them. For the private 
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hospital Hc, they state clearly that the hospital is not interested in implementing VMI agreement 
with other suppliers except for the VMI project for the supply of antiretroviral products run by 
the public manufacturer. For other types of medicines, this hospital is not interested in 
implementing a VMI approach with private suppliers. They indicate that market competition 
provides an advantage to the hospital when selecting suppliers, enabling cost efficient product 
management. So, instead of implementing VMI with a particular supplier, this hospital employs a 
traditional approach to control the stock with other suppliers. 
 
In conclusion, given the critical need for widespread medicine accessibility, the type of hospital 
does not matter for the public VMI project. However, when VMI is implemented as a private 
project hospital size does appear to matter. The largest hospital in this study possesses the 
financial, systems and human labour resources to invest in VMI adoption and also has the 
bargaining power to negotiate with the private supplier, which is not the case for the smaller 
hospitals.  
 
Top management commitment 
In both VMI projects it is clear that top management commitment can affect the feasibility of 
adopting a VMI approach. The decision to initiate and engage in a VMI project depends on the 
hospital’s management board. Without such a decision, it is impossible for VMI projects to be 
initiated. For the public VMI projects, top management has considered in each case the benefits 
to be gained from the VMI approach with the public manufacturer, in which the hospital bears 
less risk.  Owing to this, the VMI project is used to manage and monitor the stock for 
antiretroviral products.  
 
As noted earlier, the initiation of a VMI collaboration program is typically from the hospital side. 
Following top management approval for the private VMI project, several meetings were 
conducted as VMI adoption requires the involvement from different parties, which includes 
representatives from supplier's side, pharmacists, IT staff, and third-party logistics expertise. 
These meetings were held to discuss the issues related to this collaboration including internal and 
external IT integration, the contract, and product characteristics. However, ultimately it was 
decided that VMI should be implemented only for a less complicated product than 
pharmaceuticals. Thus, the designed VMI project was ultimately implemented only for a 
relatively simple product - the normal saline solution - instead of pharmaceutical products. This 
is not classified as a pharmaceutical product by the hospital. Therefore, top management can 
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affect the likelihood of VMI adoption and there may be a reluctance to engage in a different 
inventory management approach for critical pharmaceutical products if risks are perceived to be 
high. 
 
Willingness to share information 
For the public VMI project, the hospitals and the manufacturer have developed mutual trust and 
therefore the hospitals are willing to share information with the manufacturer. The hospitals are 
comfortable in sharing sensitive information with the public sector manufacturer because it is 
aware that the manufacturer will not take commercial advantage of any sensitive information on 
demand or inventory as the project is for non-profit purposes. Therefore, the hospital is 
prepared to engage in VMI adoption with the manufacturer.  
 
On the other hand, none of the hospitals are currently employing VMI projects with private 
suppliers or distributors for pharmaceutical products. For the private VMI project, after some 
consideration the hospital decided that it did not want to lose control over the management of 
pharmaceutical stocks under VMI adoption, perceiving risks in sharing information with the 
private sector distributor. Even though the purpose of the VMI project with the public hospital 
aims to enhance strategic collaboration with trading partners and enable benefits to both parties, 
ultimately the hospital was not willing to share sensitive information with the private sector 
distributor.  
 
4.3 Product characteristics 
From the case studies, if VMI adoption is under consideration, hospitals prefer to initiate and 
implement this approach for products with smooth demand rather than the fluctuating demand. 
This is because the demand is predictable and the hospital is able to estimate the stock level that 
should be prepared. This also allows the hospital to assess whether the suppliers make justified 
decisions for the replenishment quantities. In contrast, for products with fluctuating demand, the 
hospital wants to maintain control of the stock by itself as it does not want to risk a stock out 
occurrence.  For the private project, even though VMI for pharmaceutical products has been 
terminated, the hospital continues to pilot a VMI project with the saline solution products, 
which have a fairly constant and predictable demand pattern. 
 
The public sector project has successfully implemented VMI to control the stock for vital 
products. HIV disease is a serious problem in the country and the government has sought to 
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ensure that all patients are able to access the appropriate products and services. Again, the 
characteristics of antiretroviral product can be categorized as a smooth demand and the stock 
level is easy to monitor because each hospital knows the number of registered patients with the 
condition. Therefore, antiretroviral products are selected to operate under VMI approach. In 
addition, the national healthcare scheme reimburses the cost for these products which means the 
hospital does not bear the costs for the product or for VMI implementation. From the hospital's 
side, it is attractive for them to enroll in this public VMI project.  
 
In general, for hospitals, it is difficult to decide which products to consider for the 
implementation of a VMI approach. A further commercial issue is also evident in these cases. 
The market typically consists of several brands and substitute products in the same therapeutic 
groups. Hence a hospital may not want to adopt the collaborative approach with a particular 
supplier if it restricts access to alternative products as it may be able to gain commercial 
advantage from market competition.  Cost-effectiveness is critical for hospitals of all types. 
Therefore, a hospital may prefer to gain advantage by protecting its bargaining power to source 
various substitute products in the market. This is evidenced by the case studies. For the private 
VMI project, the hospital is reluctant to implement VMI for pharmaceutical products with a 
particular supplier.  For the public VMI project, the public manufacturer is authorized to provide 
medicine supplies for all contracted hospitals and hospitals find it easy to agree to be dependent 
on this supplier for this class of product.  
 
4.4 Supply chain characteristics 
Supply chain integration  
The private VMI project that was initiated between hospital HA and the major distributor aimed 
to replace the traditional replenishment approach with a VMI approach. The VMI project was 
designed and it was planned to facilitate information sharing between the hospital and the 
distributor electronically. The hospital initially considered implementing this approach with the 
low value product with smooth volumes that the hospital obtains from the distributor. The 
distributor was willing to bear the cost for the information system while the hospital was 
responsible for the cost of purchased products. However, the program for pharmaceutical 
products is currently discontinued. It was found that the hospital was ultimately reluctant to 
implement VMI for medicines. The hospital remained skeptical of employing this collaborative 
approach with the distributor. This is because the priority of the hospital is a healthcare 
perspective rather than an inventory management perspective. Employing a VMI approach 
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transfers the responsibility in controlling medicine stocks to the supplier while the hospital has to 
bear risk if the supplier fails to perform efficiently. Stockout problems can affect directly on 
patient care and are unacceptable for the hospital. Therefore, losing control over medicine 
supply appears to be viewed as risky for this hospital. VMI is now piloted by HA with one 
product only, the standard saline solution.  This product is not classified in the pharmaceutical or 
medicines category by this hospital and inventory management is less complicated than for the 
supply of medicines.  
 
The public VMI project was launched as part of a National health project, initiated by the 
manufacturer with the involvement of the contracted hospitals, including hospital HA, HB and 
HC. It is less complicated than the project between HA and the distributor. In these public 
projects, the issues discussed between the VMI implementers in each dyad are the 
communication channel, information management issues and the authorized representatives that 
will participate in the VMI approach. The project has discarded the purchasing and document 
creation processes for antiretroviral products in each dyad, which motivates each of the hospitals 
to be involved in the project. In this case, the manufacturer bears the cost for setting up the 
information system. The costs of the products are reimbursed by the National Health authority.   
 
In conclusion, the two VMI projects differ in scale with the public VMI project involving a 
number of hospitals. The hospitals bear little risk under the public project as they do not have to 
bear the cost for products or for the supporting information systems. Thus, the VMI project 
operated as a public project has proved to be more sustainable than the private project. 
 
Flow of information 
The cases reveal three aspects to be considered, including the medium for sharing information, 
the type of information, and product standardization. Firstly, for both the public and private 
projects, electronic information systems are considered necessary to facilitate information 
sharing within all dyads. The similarity between these VMI projects is that the supplier is 
responsible for investing and developing web-based portals as a medium to share information 
with the hospital. As the manufacturer and distributor gain advantage from this demand data, it 
permits better resource utilization for production and transportation. However, the IT 
applications have to be easy to use and to access to persuade hospitals to share information with 
suppliers.  
 
23 
 
Secondly, for the private VMI project, it was considered that the IT system would allow the 
distributor to see both the actual stock level and the demand level for the selected VMI 
products. It was originally planned to set up an agreed minimum and maximum level for each 
VMI product so that the distributor was able to calculate the replenishment quantities. However, 
in this VMI implementation, the distributor needed to propose the replenishment quantities to 
the hospital, allowing the hospital to make a final decision for the replenishment. This shows 
reluctance on the part of the hospital to cede full control of inventory supply for its 
pharmaceutical products to a private sector distributor.  For the public VMI project, the hospital 
has only to specify the total number of registered HIV patients with the manufacturer. 
Moreover, each week the responsible pharmacist keys in the stock levels on the web-portal and 
the manufacturer uses these data to decide the replenishment quantities. Thus all parties benefit 
from the simplicity of the system. Thirdly, standard product identification has been considered as 
it can ensure that both parties (supplier and hospital) communicate efficiently and information 
flows smoothly.  For the public VMI project, all hospitals employ standardized product 
identification while, for the private VMI project, both parties use their own product code and the 
distributor is responsible for translating the hospital's product code to its own code.  
 
In conclusion, the flow of information is a key factor to encourage VMI adoption. For all VMI 
dyads, the supplier is responsible to invest and develop information systems that enable 
information sharing. The ease of use and accessibility of IT systems persuades the hospitals to 
share the necessary data with its suppliers. Additionally, if product code standardization is 
employed, it enables a smooth flow of information. However, in the cases where the same 
product code is not employed, the supplier may need to put in extra effort to map and transform 
this data. Interestingly, even though the hospital agrees to share the information, the hospital still 
wants to be involved in the replenishment decisions in some cases as exemplified by the private 
VMI project.  
 
Flow of material 
Regarding the flow of material and also the ownership of product, it is similar to the previous 
traditional inventory management approach but only the responsibility of the VMI supplier has 
changed under VMI project. For both VMI projects, the supplier is responsible for delivering 
products directly to each hospital’s central warehouse. The products are stocked at the central 
hospital warehouse and then distributed internally by hospital staff to the appropriate 
storerooms. The ownership is transferred to the hospital when the product is received at the 
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hospital. To ensure an efficient flow of material, performance measurement has been considered. 
Under the public VMI project, checks are made by the hospital regarding on-time delivery, the 
delivery accuracy, the document accuracy and the product quality. Even though hospitals still 
experience some delivery delays under the VMI project with the public manufacturer, overall the 
hospitals are satisfied with the public manufacturer's performance in operating and managing the 
system using a VMI approach.  For the private VMI project, key performance indicators were set 
to assess the distributor's performance in terms of delivery performance and the stock fulfillment 
performance. For the delivery performance, it is similar to the public VMI project - the hospital 
checks the percentage of inaccurate documents, inaccurate product quantities, and the accuracy 
of delivery lead time. Stock fulfillment performance focuses on percentage of stock outs, 
inaccurate advance shipping notice documents (ASNs), the justification of proposed 
replenishment quantities, and accuracy of delivery consistency with the ASN document. In 
conclusion, the flow of material and ownership of product under a VMI approach is similar to 
the inventory management operating under the traditional approach. Also, key performance 
indicators are used to assess the efficient flow of material operated by the suppliers and the 
performance outcomes of the suppliers affect the feasibility and continuation of this 
collaborative approach. 
 
Relationship and trust between supplier and hospital 
For the private VMI, the collaboration between the supplier and hospital depends on the 
product type. For some particular products, if it can be supplied by various suppliers and also 
can be substituted by other products in the same therapeutic category, the hospital was ultimately 
reluctant to develop a long term relationship with one particular supplier. Vigorous competition 
promotes high performance in delivery and lower prices of medicines, which benefits the 
hospital. Also suppliers and hospitals seem in some cases to have adversarial objectives. A 
supplier aims at enhancing revenue by pushing products to the hospital while the hospital has to 
consider cost-effectiveness before selecting the product. Therefore, the relationship between 
hospital and supplier is more likely to be developed based on contractual agreements. However, 
when comparing the bargaining power in the private VMI project, it shows that the hospital is 
more powerful. It is evident that the hospital was dominant in the decisions made about VMI 
adoption as this project was initiated by the hospital and then later discontinued by the hospital. 
On the other hand, the public VMI project does not show actors with different perspectives. 
This is because both the hospitals and the public manufacturer have the same goal to promote 
drug accessibility. In conclusion, it can be said that the feasibility and continuation of the private 
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VMI project depends on the decision of the hospital, which tends to be the dominant actor in 
such projects. On the other hand, the mutual agreement under the public sector enables the 
public project to persuade more parties to be involved and is more sustainable than the private 
sector project.  
 
Table 3 Evidence from the case studies 
Theme and associated questions (see  
supplier and hospital questionnaires) 
Evidence from the case study 
Supplier Characteristics 
Type of supplier 
1.1 Do you implement VMI? 
1.3 Who has you initiated the project? 
 
 Three hospitals informed that they currently 
implement VMI with only the public supplier while 
they have not yet implemented VMI for 
pharmaceutical products with private distributors. 
 For the private program, the distributor was 
persuaded to be involved in the program in which 
the hospital initiated.  
 
 
Supplier resources, capabilities and performance 
1.7 Does type of supplier/distributor affect the feasibility of 
VMI? 
 The public VMI program is a part of government-
led healthcare program to ensure drug availability 
and accessibility in which the public company is 
funded to operate this program.  
 The funds provided to the supplier helps the 
public manufacturer to operate a VMI approach. 
Each of the hospitals is satisfied with the VMI 
scheme operated by the public supplier as it can 
supply the required medicines as it promises.  
 Even though the private supplier has capabilities 
and resources to implement VMI with hospitals, 
the VMI approach has not been implemented with 
this type of supplier for pharmaceutical products 
for other reasons, including an unwillingness by 
the hospitals to give up control over 
pharmaceutical products.   
 
Willingness to undertake a VMI project 
2.1 Do you consider implementing VMI with customers?  
2.5 Why did you implement VMI? 
 Both public and private suppliers informed that 
they were willing to adopt the VMI 
implementation with hospitals. 
 The public supplier aims to ensure product 
availability and accessibility to HIV patients in the 
country as extensively possible. Regarding the 
private supplier, it considers engaging in the 
collaborative approach to help it to provide a 
better service to the hospital.  
Hospital characteristics 
Type of hospital  
2.9 Does type of hospital affect the feasibility of VMI? 
 
 Regarding the public VMI, each of the three 
hospitals informed that they currently implement 
the program with the public supplier to operate the 
stock for antiretroviral products.  
 For the private VMI, only HA initiated VMI project 
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with the private supplier and several meeting were 
conducted to discuss the issues related to VMI 
adoption.  
 HB discussed that distributors may not be 
interested in implementing VMI projects with 
them due to the small size of the hospital. 
 For Hc, it has said that it is not interested to adopt 
VMI with other suppliers as the hospital makes 
decisions on supplier selection based on the 
previous supplier’s performance and on product 
price. Implementing VMI with a particular supplier 
may affect the hospital’s advantage in this regard. 
 
Top management commitment 
Additional question: How does top management 
commitment affect the feasibility of VMI ? 
 It was clearly stated that top management 
commitment enables the hospitals to decide to 
implement VMI with the public supplier whereas 
no hospitals implements the VMI with the private 
distributor. Without commitment from the top 
management, it is not possible to employ this 
collaborative approach. 
 Private VMI project clearly illustrates that this 
aspect has both a positive and negative impact on 
VMI adoption and implementation at the hospital. 
Initially, the support from top management enables 
the project to be initiated. Later, it was decided that 
VMI should be implemented only for a less 
complicated product than pharmaceuticals and the 
project was terminated. 
Willingness to share information 
Additional question: Are you willing to share information 
with the supplier/distributor? 
 It is stated that all hospitals share information with 
the public supplier via a website created by the 
supplier while none currently share information 
with other suppliers. 
Product characteristics 
2.10 For which type of product do you /did you implement 
VMI? 
2.11 What is the demand variation for VMI products? 
2.14 Do product characteristics affect the feasibility of 
VMI implementation? 
 
 All hospitals implement VMI to control 
antiretroviral products, which are characterised as 
smooth demand product with its suppliers.  
 HA stated that it would prefer to implement VMI  
with the smooth demand products as it is easier to 
implement, easier to check and less risky. 
Supply chain characteristics 
Current supply chain integration 
1.1 Do you implement VMI? 
 It was stated that all three hospitals currently 
implement VMI approach with the public supplier.  
 For the private project, HA is currently   
implementing the traditional approach with its 
private distributor.   
 
Type of information  
1.20, 2.19 What is the level of information integration? 
1.21, 2.20 Which types of demand data do you share with 
your suppliers/distributor? 
 
 For the public project, the hospitals were asked to 
share some necessary patient information required 
by the supplier to enable effective VMI.  
 In terms of private program, the hospital stated 
that it would allow the distributor to see hospital’s 
inventory status. 
 
Medium for information sharing  All hospitals confirmed that they are now sharing 
information via the website created by the public 
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1.18, 2.17 How is the replenishment decision made? 
 
supplier.  
 For the private VMI project, information is not 
shared with the distributor as VMI is not currently 
conducted. The hospital still manages and controls 
stocks for pharmaceutical products using a 
traditional approach. Orders generated by the 
hospital are sent to the distributor. 
 
Flow of material 
Additional question: How do you manage product 
delivery? 
 The hospitals indicate that the flow of material 
under VMI is still the same as under the traditional 
approach. 
 
Relationship and trust 
Additional question: How do you manage the VMI 
contract? 
 For the public VMI, it was suggested that the 
hospital who agree with the VMI project then 
decide to implement it. This presents the mutual 
agreement from both parties.  
 For the private VMI, it was considered to be a 
contract agreement between both parties. 
 
 
  Table 4: Summary of findings 
 Theme Private VMI project Public VMI project 
Supplier characteristics  
Type of supplier 
 
 
Supplier resources, capabilities 
and performance 
 
Willingness to undertake a VMI 
project 
 
 
Private distributor (D) 
 
 
Capable to do this task 
 
 
 
Yes 
 
Public manufacturer (M) 
(Initiator) 
 
Capable to do this task 
 
 
 
Yes 
Hospital characteristics 
Type of hospital 
 
 
 
Top management commitment 
 
Willingness to fully share 
information 
 
 
University hospital (HA) 
(Initiator) 
 
 
Positive and negative 
 
 
No 
 
University hospital (HA), Provincial 
hospital (HB), private hospital (Hc) 
 
 
Positive 
 
 
Yes 
Product characteristics 
 
Smooth demand products 
 
Antiretroviral products 
Smooth demand 
Free products 
Supply chain characteristics 
Current supply chain integration 
 
 
 
Discontinued VMI 
 
 
Continued using VMI 
 
Type of information  
 
 
 
Inventory level and demand 
level was expected to be 
shared 
 
Number of beneficiaries, actual 
demand and Stock on-hand level 
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 Theme Private VMI project Public VMI project 
 
Medium for information sharing 
 
 
It was expected to share via 
Web-based portal 
 
Web-based portal 
 
Flow of material Delivers to hospital’s 
central warehouse 
 
Delivers to hospital’s central 
warehouse 
Relationship and trust Based on contract 
agreement 
Develop mutual agreement 
 
5. DISCUSSION 
It has been noted that the hospital industry lags behind in adopting collaborative inventory 
management approaches compared to the retail and manufacturing sectors (Chen et al., 2013). 
With limited knowledge on collaborative approaches and the priority being on clinical tasks, 
inventory management can be of less concern in hospitals (Bhakoo et al., 2012, Chen et al., 
2013).  Only a few studies have been conducted to date on VMI adoption in hospital contexts 
(Bhakoo et al., 2012; Guimaraes et al., 2012; Watson et al., 2012). Our study has gone beyond 
these studies in examining VMI in a multi-hospital public supply context and examining a VMI 
project that was terminated. We have compared two cases of VMI for pharmaceutical supplies in 
a hospital context – a success and a failure - from multiple perspectives. These involved four 
dyadic relationships. Neither of the cases has been discussed in the literature previously. The 
study provides new insights on VMI adoption in a hospital pharmaceutical context and furthers 
existing knowledge.  It shows that the VMI approach can be adopted within the hospital context 
for pharmaceutical products. However, the adoption of VMI for pharmaceutical supplies raises 
issues and challenges for both the supplier and the hospital.  
The literature argues that the type of VMI can be expected to differ in different industries, 
different   supply chain contexts and depending on which parties implement it (Elvander et al., 
2007;Zammori et al., 2009; Niranjan et al., 2012). There have been very few studies focused on 
examining specifically VMI adoption for hospital pharmaceuticals (Kim, 2005; Watson et al., 
2012; Guimaraes et al. 2013). This study has therefore contributed new empirical evidence by 
examining VMI in a hospital pharmaceutical context for a public and a private VMI project, 
showing that in some contexts VMI can operate successfully. The literature argues that supplier 
characteristics are related to the feasibility and success of VMI adoption (Vigtil, 2008; Niranjan et 
al., 2012).  This study has gone further by considering four aspects that affect VMI in a hospital 
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pharmaceutical context - supplier characteristics, hospital characteristics, product characteristics 
and supply chain characteristics.  The study shows that suppliers can be in either the public or 
private sector and also highlights the importance of the role of the pharmaceutical distributor. 
Previous studies have not considered how hospital characteristics affect the feasibility of VMI 
adoption specifically. This study contributes significant evidence that, for public sector projects, 
all types of hospitals can be involved in a successful VMI project. However, for a private VMI 
project, the study indicates that large hospitals are most likely to have both the potential and 
power to adopt and lead this approach but only if they deem it to be in their interests. Previous 
studies have suggested that trust issues are related to successful VMI implementation (Bhakoo et 
al. 2012, Stanger 2013, Brinkhoff et al., 2015). This study provides new insights on the factors 
that can cause hospitals to resist VMI adoption.   
The literature is still inconclusive on which types of products are suitable for the VMI approach 
in general or specifically in the context of hospital inventory items (Vigtil, 2008; Niranjan et al., 
2012; Govindan, 2013). Some studies argue that pharmaceutical supplies are less appropriate for 
a VMI approach than non-pharmaceutical inventory items (Bhakoo et al., 2012; Matopoulos and 
Michailidou, 2013). This study shows that VMI may be most appropriate for pharmaceutical 
products with smooth demand characteristics. Some literature sources have suggested that VMI 
can provide more favorable cost benefits to the retailer than the supplier in retail supply contexts 
(Govindan, 2013)  and some previous studies suggest that VMI enhances cost reduction in the 
hospital (Kim, 2005; Matopoulos and Michailidou, 2013). This study indicates that a Public VMI 
can enhance cost reduction at the hospital as it reduces purchasing and administration costs 
when the supplier bears the cost of IT implementation. We discuss these contributions in more 
detail below.   
Two types of VMI implementation are evident in this study:  public sector and private sector 
VMI.  The public VMI initiative was launched under a national healthcare project while the 
private project was trialed between a large hospital and a private distributor. Both types of VMI 
project demonstrate asymmetric dependencies between supply chain partners. Both projects 
were initiated and negotiated by the player with the most bargaining power. For the public-sector 
VMI project, the project is negotiated by the public sector manufacturer and is offered and 
operated regardless of the type or location of the hospital with the goal to enhance product 
accessibility to patients. The private VMI project, initiated by the hospital, emphasized enhancing 
inventory management at the hospital and improving customer service. This is consistent with 
the study of Brinkhoff et al., (2015) on inter-organizational supply chain projects - when the 
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organization with higher bargaining power perceives benefits to be gained from a collaborative 
approach such as VMI, it is likely the project will be negotiated and initiated. 
 
Additionally, organizational size affects the feasibility of VMI and its likely adoption. Such 
projects are typically negotiated by the larger sized organization, either the hospital or the 
supplier. Compared with smaller organizations, the larger sized organization is likely to have 
more access to finance and human resources, and can bear the costs of IT adoption and the cost 
of changing systems (Kuk, 2004; Borad and Bansod, 2010; Bhakoo et al., 2012). Regarding the 
private VMI project, the hospital considered implementing the project with the distributor as it is 
one of the hospital’s largest suppliers, providing it with a high volume of medicines. As a 
multinational company, the distributor is able to invest in the technology required to enable 
information sharing, which meets the hospital’s needs. Also, this private distributor is willing to 
engage in the VMI project as the hospital is one of its key customers. This concurs with the 
observation of Niranjan et al. (2012) that VMI may be appropriate if the customer constitutes a 
high percentage of the supplier’s sales.  On the other hand, the size of organization is not a 
factor for the public manufacturer in terms of hospital size as it is willing to implement the 
scheme with various types of hospital to ensure product availability for patients. Thus, the 
guiding objective of the project may also influence the likelihood, feasibility and the scale of VMI 
adoption.   
 
Apart from the scale and objective of VMI projects, a major difference between these two 
projects is that the public sector project has continued while the private project was terminated. 
The discontinuation of the private VMI project highlights the multiple stakeholders that are 
involved or that can affect decisions on inventory management systems in a hospital context (de 
Vries, 2011).  A successful inventory project initiative depends upon a coalition of different 
stakeholders within the hospital. For healthcare professionals, the focus is much more on patient 
care than inventory management.  Moreover, there are a number of reasons evident from the 
study for the resistance by the hospital to transferring full control of pharmaceuticals to the 
supplier. These hospital-related issues have not been identified in the literature previously. 
Firstly, the hospital may perceive risks from stock outs when transferring this critical task to 
outside parties. Stock outs in hospitals should not occur, or occur rarely, as they can cause 
deterioration of patients or lead to patient mortality. Secondly, the hospital may be concerned 
that the supplier may take advantage from this opportunistic situation by replenishing a large 
quantity of stock and hold higher stocks at the hospital than is required. The third issue is job 
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redundancy as previously the stock is managed by the healthcare staff or the pharmacists with 
inventory management responsibilities. Therefore, each of these issues needs to be considered 
when designing, implementing and operating a collaborative VMI approach in a hospital context. 
 
The study shows that supplier, hospital, and product characteristics, as well as supply chain 
integration, can influence the VMI adoption decision in the hospital pharmaceutical supply 
chain. In particular it may be difficult for the hospital to give up its bargaining power and be 
dependent on a particular supplier. Based on the insights gained from the study, 
recommendations can be made for hospitals when piloting the VMI collaborative approach. 
Firstly, it is suggested to pilot a VMI project with products supplied by a single supplier. To 
illustrate the point, an original patented product that does not have generic competitors as it is 
protected within a 20 year patent period can be considered. For this kind of product, the supplier 
or the distributor is willing to provide the service to the hospital as it can ensure its sales volume. 
Therefore, it may be a win-win situation for both parties. Also, it may be a local product 
produced under a public VMI project in which the public manufacturer is a single supplier with 
exclusive rights to operate the project. However, it may not be easy to negotiate a pilot project 
unless the supplier is also interested in this collaboration. 
 
Secondly, it is recommended to pilot a VMI project with smooth demand products. The study 
indicates that hospitals prefer to implement VMI to monitor stock for products with smooth 
demand rather than fluctuating demand because the demand is predictable and the hospital is 
able to estimate the stock level that should be prepared. This allows the hospital to assess 
whether the supplier makes justified decisions for the replenishment quantities.  In contrast, for 
products with fluctuating demand characteristics, the hospital may still want to control the stock 
itself as it does not want to risk a stock out occurrence.  Initially, the hospital may not fully 
authorize the distributor to operate and make a replenishment decision. However, for smooth 
demand products, previous demand history allows the hospital to evaluate whether the 
distributor can operate efficiently without exploiting the opportunities afforded by demand 
visibility. 
 
Our study highlights the important role of the public sector in accelerating VMI adoption in a  
hospital context to manage the stocks of vital products such as antiretroviral medicines for HIV 
patients. Hospitals of all kinds may perceive fewer risks in participating in such public sector 
projects in contrast to engaging in VMI with private sector distributors. This highlights the issue 
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that government support and public health policy may be beneficial in enabling successful VMI 
approaches in some contexts. This kind of collaborative approach can bring benefits to both the 
public supplier and hospitals and can also contribute to social welfare. Publicly managed VMI 
projects may enable greater access to the medicines necessary to control critical diseases or 
epidemics. The public supplier is able to manage stock efficiently while ensuring product 
accessibility to all patients. If supply is financially supported under a national healthcare program 
and the stock is operated by the VMI supplier, it allows the hospitals to reduce purchasing and 
administration costs for these products. Also, such VMI approaches may enable the hospitals to 
avoid the problems caused by stock outs or excess stock for these particular products, which 
may also facilitate cost reduction. In terms of social welfare, efficient inventory management 
allows patients to have access to affordable medicines on the basis of need. This helps patients in 
gaining a better quality of life and supports governments in preventing epidemics. The successful 
case study in antiretroviral product should encourage the public sector to consider this 
collaborative approach for other vital products.   
6. CONCLUSIONS 
This study has investigated VMI adoption in hospital pharmaceutical supply chains with respect 
to four aspects - hospital, supplier, product, and supply chain integration characteristics. The 
research was based on two projects in Thailand that involved a number of dyads.  Two types of 
VMI initiatives are identified, public and private.  The public project was launched under a 
national healthcare project while the private project was initiated between a large hospital and a 
private distributor. Differences between these two projects have affected the success of VMI 
adoption and its continuation.  The public VMI project shows that successfully implementing 
VMI with a single supplier is possible but in a specific context where hospitals perceive little risk 
and bear no costs. However, when a hospital initiated VMI with its private distributor, the 
perceived risks led to the discontinuation of the project. The study highlights that there may be a 
reluctance on the part of a hospital to hand over the responsibility for inventory management for 
medicines to a private distributor because of the perceived risks of losing internal control of 
critical supplies of medicines. Additionally, there may be commercial concerns about a ‘lock-in’ 
situation with a particular supplier when there are potentially many alternative brands available in 
many therapeutic medical categories. The research literature needs to provide much clearer 
insights and more convincing guidance on the benefits that may be gained from VMI adoption 
in hospital pharmaceutical supply chains, particularly with respect to product characteristics and 
actual rather than perceived risks. Additionally, more study is needed on the costs versus benefits 
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in hospital pharmaceutical contexts for all parties involved in collaborative supply chain 
initiatives such as VMI.  
The study provides new empirical evidence on VMI in hospital pharmaceutical supply chains. A          
limitation of this research is that all cases have been conducted in one country, which may affect 
the generalization of the findings.  Although Thailand has a well developed modern healthcare 
system, wider empirical evidence from other countries in both developed and less developed 
regions will be beneficial.  Further work on potential benefits and disadvantages for 
pharmaceutical products with different demand characteristics is advocated, as well as studies 
probing more deeply the risks in VMI from the perspective of the hospital and the supplier. 
Also, there is a potential for the public sector to implement VMI approaches more widely to 
control the stocks of vital medicines in hospitals so as to ensure the product accessibility to 
patients. Hence, there is a need for further research to explore how public policy can promote 
and enable collaborative approach to enhance availability and public health. Lastly, hospitals 
typically use the concept of FIFO (First in First out) and FEFO (First expired First Out) to 
control stock as medicines are often perishable products. Hence, future research should consider 
how VMI may be able to offer enhanced solutions to support the inventory management of 
pharmaceutical products in hospitals taking into account the perishable nature of many products.  
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Appendix: Summary of interview questions for hospitals and distributor/manufacturer 
The appendix is divided into two sections.  Section 1 provides a summary of the interview questions for 
hospitals and section 2 provides a summary of the questions for distributors/manufacturer. 
 
Section 1: Questions for VMI hospitals 
1.1 Do you implement VMI?  
1.2 If no, did you consider VMI and/or why did you abandon a VMI project? 
1.3 Who has initiated the project? 
1.4 How long have you implemented VMI?  
1.5 Why do you implement VMI? 
Supplier characteristics 
1.6 Does the type of supplier/distributor affect the level of your bargaining power? 
1.7 Does type of supplier/distributor affect the level of data integration? 
1.8 Does type of supplier/distributors affect the feasibility of VMI implementation? 
1.9 Does type of supplier/ distributor affect performance outcomes of VMI? 
Product characteristics 
1.10 For which type of products do you implement VMI?        
1.11 Are they brand name products or generic products?        
1.12 How stable is demand for VMI products?        
1.13 How do you classify type of VMI products based on the level of demand?        
1.14 Are they fast moving or slow moving products?        
1.15 Do product characteristics affect the feasibility of VMI implementation? 
Collaboration characteristics 
1.16 How is inventory ownership transferred? 
1.17 What is the control limit option for products that currently are managed by VMI? 
1.18 How is the replenishment decision made? 
1. 19 Who makes the shipment decision? 
1.20 What is the level of information integration? 
1.21 Which type of demand data do you share with your suppliers/distributor? 
Benefits and challenges of VMI approach 
1.22 Have you experienced benefits gained from VMI approach? 
1.23 What kind of benefits do you gain from this approach hospital? 
1.24 Which costs have been affected by VMI approach? 
1.25 Are there any challenges for VMI implementation? 
Section 2: Questions for VMI distributors/manufacturers 
2.1 Do you consider implementing VMI with customers?  
2.2 Do you still implement VMI?  If no, why did you abandon the project? 
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2.3 Who have you initiated VMI projects with? 
2.4 How long have you been using VMI? 
2.5 Why did you implement VMI? 
Hospital characteristics 
2.6 What is the level of your bargaining power with your customers? 
2.7 Does type of hospital affect the level of your bargaining power? 
2.8 Does type of hospital affect the level of data integration? 
2.9 Does type of hospital affect the feasibility of VMI implementation? 
Product characteristics 
2.10 For which type of product do you /did you implement VMI?        
2.11 What is the demand variation for VMI products?        
2.12 How would you classify the type of VMI product based on the level of demand?        
2.13 How stable is the price for VMI products?        
2.14 Do product characteristics affect the feasibility of VMI implementation? 
Collaboration characteristics 
2.15 How and when is inventory ownership transferred? 
2.16 What is the stock control limit options for products that currently adopt VMI? 
2.17 How is the replenishment decision made? 
2.18 Who makes the shipment decision? 
2.19 What is the level of information integration? 
2.20 Which type of demand data do you obtain from the hospital (s)? 
Benefits and challenges of VMI approach 
2.21 Have you experienced benefits gained from using a VMI approach? 
2.22 What kind of benefits do you gain from this approach hospital? 
2.23 Are there any challenges for VMI implementation? 
  
 
 
